Buscar
Mostrando ítems 31-40 de 4990
Metabolic Syndrome Criteria As Predictors of Insulin Resistance, Inflammation and Mortality in Chronic Hemodialysis Patients
(Mary Ann Liebert, Inc, 2014-10-01)
Background: Chronic kidney disease (CKD) and metabolic syndrome are characterized by overlapping disorders, including glucose intolerance, hypertension, dyslipidemia, and, in some cases, obesity. However, there are no ...
Toll-like receptor 4 D299G polymorphism in metabolic disorders: A meta-analysis
(Springer, 2013-04)
The toll-like receptor 4 (TLR4) plays a key role in the activation of innate immune response participating in the recognition of lipopolysaccharides. Changes in the innate immune response are involved in the pathogenesis ...
Chaperone mediated autophagy in the crosstalk of neurodegenerative diseases and metabolic disorders
(Frontiers Media, 2019)
Chaperone Mediated Autophagy (CMA) is a lysosomal-dependent protein degradation pathway. At least 30% of cytosolic proteins can be degraded by this process. The two major protein players of CMA are LAMP-2A and HSC70. While ...
Second Generation Antipsychotics (SGAs) in Schizophrenic Patients and Bipolar Disorder: Correlation With Metabolic Syndrome (NCEP ATP III(a))
(Canadian Center of Science and Education, 2019)
Introduction: The Metabolic Syndrome is a set of diverse clinical situations such as diabetes mellitus,
hypertension and dyslipidemia. Patients with mental illnesses such as schizophrenia or bipolar disorder have a
higher ...
Protease Inhibitor and Metabolic Alteration
(SOC CHILENA ANATOMIATEMUCO, 2013-08-02)
Protease inhibitors (PIs), part of HAART (Highly Active Antiretroviral Therap) are selective, competitive inhibitors of protease, a crucial enzyme to viral maturation, infection and replication. A lipodystrophic syndrome ...